Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
TRIDURAL PALADIN PHARMA INC. Actual shortage 100MG Updated Report 2024-06-08 229156
5% DEXTROSE INJECTION, USP BAXTER CORPORATION Actual shortage 5G Updated Report 2024-06-08 229851
ACH-FINASTERIDE ACCORD HEALTHCARE INC Actual shortage 5MG Updated Report 2024-06-08 229914
ACH-QUETIAPINE ACCORD HEALTHCARE INC Actual shortage 150MG Updated Report 2024-06-08 229917
5% DEXTROSE INJECTION, USP BAXTER CORPORATION Actual shortage 5G Updated Report 2024-06-08 229848
SODIUM CHLORIDE INJECTION USP ICU MEDICAL CANADA INC Actual shortage 9MG Updated Report 2024-06-07 228488
APO-PERINDOPRIL APOTEX INC Resolved 8MG Updated Report 2024-06-07 229416
APO-ATORVASTATIN APOTEX INC Resolved 40MG Updated Report 2024-06-07 229401
APO-AMIODARONE TABLETS APOTEX INC Resolved 200MG Updated Report 2024-06-07 228816
APO-MELOXICAM APOTEX INC Resolved 15MG Updated Report 2024-06-07 229422
APO-GLICLAZIDE APOTEX INC Resolved 80MG Updated Report 2024-06-07 224583
APO-GLICLAZIDE APOTEX INC Resolved 80MG Updated Report 2024-06-07 225799
APO-CEPHALEX APOTEX INC Actual shortage 500MG Updated Report 2024-06-07 225020
APO-CEFEPIME APOTEX INC Actual shortage 2G Updated Report 2024-06-07 228807
APO-CEFEPIME APOTEX INC Actual shortage 1G Updated Report 2024-06-07 227082
APO-AMLODIPINE-ATORVASTATIN APOTEX INC Resolved 80MG 10MG Updated Report 2024-06-07 219843
APO-AMLODIPINE-ATORVASTATIN APOTEX INC Resolved 40MG 5MG Updated Report 2024-06-07 229404
CIPRO ORAL SUSPENSION BAYER INC Anticipated shortage 500MG Updated Report 2024-06-07 229988
UROMITEXAN BAXTER CORPORATION Actual shortage 100MG Updated Report 2024-06-07 228511
ACCUTANE ROCHE HOFFMANN-LA ROCHE LIMITED Anticipated shortage 40MG New Report 2024-06-07 229983
ACCUTANE ROCHE HOFFMANN-LA ROCHE LIMITED Anticipated shortage 10MG New Report 2024-06-07 229980
HAVRIX 1440 GLAXOSMITHKLINE INC Actual shortage 1440UNIT Updated Report 2024-06-07 229977
APO-RILUZOLE APOTEX INC Anticipated shortage 50MG New Report 2024-06-07 229974
XARELTO BAYER INC Anticipated shortage 10MG New Report 2024-06-07 229971
ACH-ROSUVASTATIN ACCORD HEALTHCARE INC Actual shortage 5MG Updated Report 2024-06-07 218314
TEVA-ALMOTRIPTAN TEVA CANADA LIMITED Actual shortage 12.5MG New Report 2024-06-07 229966
DOXORUBICIN HYDROCHLORIDE INJECTION TEVA CANADA LIMITED Actual shortage 2MG New Report 2024-06-07 229963
TEVA-ERLOTINIB TEVA CANADA LIMITED Actual shortage 100MG New Report 2024-06-07 229960
TEVA-ERLOTINIB TEVA CANADA LIMITED Actual shortage 25MG New Report 2024-06-07 229957
TEVA-ATORVASTATIN TEVA CANADA LIMITED Actual shortage 40MG New Report 2024-06-07 229954
TEVA-MELOXICAM TEVA CANADA LIMITED Actual shortage 15MG New Report 2024-06-07 229951
TEVA-PRAVASTATIN TEVA CANADA LIMITED Actual shortage 10MG New Report 2024-06-07 229948
TEVA-BUSPIRONE TEVA CANADA LIMITED Actual shortage 10MG New Report 2024-06-07 229945
CEFOXITIN FOR INJECTION TEVA CANADA LIMITED Actual shortage 2G New Report 2024-06-07 229942
TEVA-TOPISONE TEVA CANADA LIMITED Actual shortage 0.05% New Report 2024-06-07 229939
TEVA-FUROSEMIDE TEVA CANADA LIMITED Actual shortage 40MG New Report 2024-06-07 229936
TEVA-SOLIFENACIN TEVA CANADA LIMITED Resolved 5MG Updated Report 2024-06-07 195652
TEVA-ZOPICLONE TEVA CANADA LIMITED Resolved 5MG Updated Report 2024-06-07 183386
TEVA-CEPHALEXIN 250 TEVA CANADA LIMITED Resolved 250MG Updated Report 2024-06-07 227459
TEVA-BUPROPION XL TEVA CANADA LIMITED Resolved 300MG Updated Report 2024-06-07 224445
TEVA-BUPROPION XL TEVA CANADA LIMITED Resolved 300MG Updated Report 2024-06-07 223856
TEVA-RIVAROXABAN TEVA CANADA LIMITED Actual shortage 20MG Updated Report 2024-06-07 227456
TEVA-DULOXETINE TEVA CANADA LIMITED Actual shortage 30MG Updated Report 2024-06-07 215751
TEVA-DULOXETINE TEVA CANADA LIMITED Actual shortage 60MG Updated Report 2024-06-07 226945
TEVA-BUPRENORPHINE/NALOXONE TEVA CANADA LIMITED Actual shortage 2MG 0.5MG Updated Report 2024-06-07 221534
TEVA-BUPRENORPHINE/NALOXONE TEVA CANADA LIMITED Actual shortage 2MG 8MG Updated Report 2024-06-07 221537
ACT METHYLPHENIDATE ER TEVA CANADA LIMITED Actual shortage 54MG Updated Report 2024-06-07 228143
CISPLATIN INJECTION, BP ACCORD HEALTHCARE INC Anticipated shortage 1MG Updated Report 2024-06-07 225228
TEVA-CINACALCET TEVA CANADA LIMITED Actual shortage 30MG Updated Report 2024-06-07 224907
TEVA-CINACALCET TEVA CANADA LIMITED Actual shortage 60MG Updated Report 2024-06-07 224910

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
GLUCONORM 2.0MG NOVO NORDISK CANADA INC To be discontinued 2.0MG Updated Report 2024-06-05 201489
ISENTRESS MERCK CANADA INC To be discontinued 100MG Updated Report 2024-06-04 204160
PRO-DESVENLAFAXINE PRO DOC LIMITEE Discontinued 100MG New Report 2024-06-04 229623
PRO-DESVENLAFAXINE PRO DOC LIMITEE Discontinued 50MG New Report 2024-06-04 229620
SUPREFACT DEPOT 2 MONTHS CHEPLAPHARM ARZNEIMITTEL GMBH To be discontinued 6.3MG New Report 2024-06-03 228169
BUPIVACAINE HYDROCHLORIDE INJECTION, USP STERIMAX INC Discontinued 7.5MG Updated Report 2024-06-01 216017
AVAPRO SANOFI-AVENTIS CANADA INC To be discontinued 75MG New Report 2024-05-31 229306
REPATHA AMGEN CANADA INC To be discontinued 120MG Updated Report 2024-05-24 223420
ZOVIRAX GLAXOSMITHKLINE INC Discontinued 200MG New Report 2024-05-24 228728
VITAMIN A ACID BAUSCH HEALTH, CANADA INC. Discontinued 0.01% Updated Report 2024-05-23 217835
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) SANDOZ CANADA INCORPORATED Discontinued 10000UNIT Updated Report 2024-05-18 228249
SANDOZ PRAVASTATIN TABLETS SANDOZ CANADA INCORPORATED Discontinued 20MG Updated Report 2024-05-18 228256
SANDOZ PRAVASTATIN TABLETS SANDOZ CANADA INCORPORATED Discontinued 40MG Updated Report 2024-05-18 228263
SANDOZ SENNA S SANDOZ CANADA INCORPORATED Discontinued 50MG 8.6MG Updated Report 2024-05-18 228268
SUPREFACT DEPOT 3 MONTHS CHEPLAPHARM ARZNEIMITTEL GMBH Discontinued 9.45MG Updated Report 2024-05-17 228166
ANANDRON CHEPLAPHARM ARZNEIMITTEL GMBH Discontinued 50MG Updated Report 2024-05-17 228155
FOSRENOL TAKEDA CANADA INC To be discontinued 1000MG New Report 2024-05-16 228184
FOSRENOL TAKEDA CANADA INC To be discontinued 750MG New Report 2024-05-16 228181
FOSRENOL TAKEDA CANADA INC To be discontinued 500MG New Report 2024-05-16 228178
EYE STREAM ALCON CANADA INC Discontinued 0.03% 0.048% 0.075% 0.64% New Report 2024-05-15 228021